Literature DB >> 21254848

Efficacy of clobetasol spray: factors beyond patient compliance.

Tina Bhutani1, John Koo, Howard I Maibach.   

Abstract

Clobetasol 0.05% spray, a topical clobetasol propionate, is a non-greasy formulation that has shown increased clinical efficacy in a head-to-head comparison with foam formulation. Moreover, available data from randomized, controlled, double-blind trials suggests that clobetasol spray is, in fact, slightly more effective than most, if not all, other preparations of clobetasol. The fact that clobetasol spray is exceptionally easy to comply with may have played a major role in this outcome; however, other factors must be considered. These include vehicle metamorphosis post-application as well as vehicle and excipient effects on stratum corneum permeability. Basic concepts in topical drug delivery and how they apply to this spray vehicle may further explain the greater efficacy of clobetasol spray.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21254848     DOI: 10.3109/09546634.2010.512952

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  4 in total

1.  In Vivo Assessment of Clobetasol Propionate-Loaded Lecithin-Chitosan Nanoparticles for Skin Delivery.

Authors:  Taner Şenyiğit; Fabio Sonvico; Alessandra Rossi; Işıl Tekmen; Patrizia Santi; Paolo Colombo; Sara Nicoli; Özgen Özer
Journal:  Int J Mol Sci       Date:  2016-12-26       Impact factor: 5.923

2.  Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis.

Authors:  Katrien Van Bocxlaer; Kerri-Nicola McArthur; Andy Harris; Mo Alavijeh; Stéphanie Braillard; Charles E Mowbray; Simon L Croft
Journal:  Pharmaceutics       Date:  2021-04-08       Impact factor: 6.321

3.  Mechanisms of action of topical corticosteroids in psoriasis.

Authors:  Luís Uva; Diana Miguel; Catarina Pinheiro; Joana Antunes; Diogo Cruz; João Ferreira; Paulo Filipe
Journal:  Int J Endocrinol       Date:  2012-11-05       Impact factor: 3.257

4.  Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris--A randomized phase II study.

Authors:  John Koo; Stephen Tyring; William P Werschler; Suzanne Bruce; Martin Olesen; John Villumsen; Jerry Bagel
Journal:  J Dermatolog Treat       Date:  2015-10-07       Impact factor: 3.359

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.